203 related articles for article (PubMed ID: 22027536)
21. Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review.
Gerullis H; Ecke T; Eimer C; Wishahi M; Otto T
Anticancer Drugs; 2011 Jan; 22(1):9-17. PubMed ID: 20948429
[TBL] [Abstract][Full Text] [Related]
22. [Microtubules and antineoplastic drugs].
Arioka H; Saijo N
Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790
[TBL] [Abstract][Full Text] [Related]
23. Anticancer therapy with novel tubulin-interacting drugs.
Kavallaris M; Verrills NM; Hill BT
Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
[TBL] [Abstract][Full Text] [Related]
24. New insights into Vinca alkaloids resistance mechanism and circumvention in lung cancer.
Zhang Y; Yang SH; Guo XL
Biomed Pharmacother; 2017 Dec; 96():659-666. PubMed ID: 29035832
[TBL] [Abstract][Full Text] [Related]
25. Biochemical effects of Navelbine on tubulin and associated proteins.
Fellous A; Ohayon R; Vacassin T; Binet S; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):9-14. PubMed ID: 2496470
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
27. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites.
Honoré S; Pagano A; Gauthier G; Bourgarel-Rey V; Verdier-Pinard P; Civiletti K; Kruczynski A; Braguer D
Mol Cancer Ther; 2008 Jul; 7(7):2080-9. PubMed ID: 18645018
[TBL] [Abstract][Full Text] [Related]
29. Introduction. The novel microtubule inhibitor vinflunine.
Horwitz SB
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S1-2. PubMed ID: 18538173
[No Abstract] [Full Text] [Related]
30. Selective and reversible effects of vinca alkaloids on Trypanosoma cruzi epimastigote forms: blockage of cytokinesis without inhibition of the organelle duplication.
Grellier P; Sinou V; Garreau-de Loubresse N; Bylèn E; Boulard Y; Schrével J
Cell Motil Cytoskeleton; 1999; 42(1):36-47. PubMed ID: 9915583
[TBL] [Abstract][Full Text] [Related]
31. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids.
Coderch C; Morreale A; Gago F
Anticancer Agents Med Chem; 2012 Mar; 12(3):219-25. PubMed ID: 22044006
[TBL] [Abstract][Full Text] [Related]
32. Microtubule alterations and resistance to tubulin-binding agents (review).
Drukman S; Kavallaris M
Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
[TBL] [Abstract][Full Text] [Related]
33. Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Fanale D; Bronte G; Passiglia F; Calò V; Castiglia M; Di Piazza F; Barraco N; Cangemi A; Catarella MT; Insalaco L; Listì A; Maragliano R; Massihnia D; Perez A; Toia F; Cicero G; Bazan V
Anal Cell Pathol (Amst); 2015; 2015():690916. PubMed ID: 26484003
[TBL] [Abstract][Full Text] [Related]
34. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines.
Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652
[TBL] [Abstract][Full Text] [Related]
35. Novel aspects of natural and modified vinca alkaloids.
Duflos A; Kruczynski A; Barret JM
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):55-70. PubMed ID: 12678751
[TBL] [Abstract][Full Text] [Related]
36. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules.
Himes RH
Pharmacol Ther; 1991; 51(2):257-67. PubMed ID: 1784631
[TBL] [Abstract][Full Text] [Related]
37. Interplay between microtubule dynamics and intracellular organization.
de Forges H; Bouissou A; Perez F
Int J Biochem Cell Biol; 2012 Feb; 44(2):266-74. PubMed ID: 22108200
[TBL] [Abstract][Full Text] [Related]
38. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
Kovács P; Csaba G
Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
[TBL] [Abstract][Full Text] [Related]
39. Update on tubulin-binding agents.
Attard G; Greystoke A; Kaye S; De Bono J
Pathol Biol (Paris); 2006 Mar; 54(2):72-84. PubMed ID: 16545633
[TBL] [Abstract][Full Text] [Related]
40. Indibulin, a novel microtubule inhibitor, discriminates between mature neuronal and nonneuronal tubulin.
Wienecke A; Bacher G
Cancer Res; 2009 Jan; 69(1):171-7. PubMed ID: 19118000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]